Overall, these results suggest that methylation of the 5 ́ region of ZNF677 is responsible for ZNF677 silencing in many tumor cell lines of different entities including NSCLC, breast cancer, colon cancer, ovarian cancer, pancreatic cancer and head and neck cancer. This evidence concerns the gene ZNF677 and head and neck cancer.